Viewing nowClopidogrel Tablets (Clopidogrel Bisulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

MFDS item code 201505737 · Approved 2015.08.17 · Insurance code 671704790
Treatment to improve atherosclerotic symptoms and reduce the risk of stroke in patients with ischemic stroke, myocardial infarction, etc.
This medication is used to improve atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. Additionally, it helps improve cardiovascular atherosclerotic symptoms in patients with acute coronary syndrome who have unstable angina or non-ST elevation myocardial infarction and receive or are scheduled to receive drug treatment, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG). Furthermore, in adult patients with one or more vascular risk factors where vitamin K antagonist therapy is inappropriate and with a low risk of bleeding, it reduces the risk of stroke and thromboembolism. In summary, this medication is used to improve atherosclerotic symptoms related to vascular diseases and reduce the risk of stroke and thrombosis to restore health.
For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease: Take 75 mg orally once daily. For patients with acute coronary syndrome: Start with a loading dose of 300 mg orally once daily on the first day, and thereafter take a maintenance dose of 75 mg orally once daily. In this case, aspirin 75 to 325 mg should be co-administered orally once daily. For patients with atrial fibrillation: Take 75 mg orally once daily, and aspirin 75 to 100 mg should be co-administered orally once daily.
This medication prevents platelets from aggregating, thus preventing blood from clotting. People with genetically decreased functionality of a specific enzyme (CYP2C19) may experience a reduced effect of this medication, which can increase the risk of heart attack or stroke; therefore, in such cases, treatment methods should be adjusted in consultation with a doctor. Taking this medication with drugs that activate enzymes can increase the concentration of this medication, raising the risk of bleeding, so it is advisable not to take them together. Patients who have an allergy to this medication or its components, those with bleeding disorders, severe liver damage, nursing women, or those with lactose intolerance should not take this medication. Patients at high risk of bleeding or those suspected of having bleeding symptoms should immediately undergo blood tests, and for those scheduled for surgery, it is recommended to discontinue this medication 5-7 days prior and restart only after hemostasis. Caution is required when taking this medication with other bleeding risk medications, anticoagulants, or certain antidepressants, as the risk of bleeding may increase. This medication may cause side effects related to bleeding such as gastrointestinal bleeding, bruising, nosebleeds, hematuria, thus should consult a doctor immediately if any abnormal symptoms occur. Pregnant women are advised to discontinue this medication 5-7 days prior to delivery due to an increased risk of bleeding during childbirth. In nursing mothers, as this medication may be excreted in breast milk, careful consideration should be given on whether to discontinue nursing or the medication. Elderly patients or those with impaired kidney or liver function may have an increased risk of bleeding, hence dosage adjustments and condition monitoring are necessary. In overdose situations, the risk of bleeding increases, and since there is no specific antidote, measures such as platelet transfusion may be necessary in case of significant bleeding. To ensure safety for children, this medication should be stored out of reach of children, and transferring it to another container may alter its quality, so caution is advised.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, peeling skin, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air, ideally at room temperature between 1 degree and 30 degrees. By storing it this way, the effectiveness of the medication is maintained for safe use.
Pink round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.